PAOLINI PAOLETTI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 923
AS - Asia 798
EU - Europa 484
SA - Sud America 95
AF - Africa 17
OC - Oceania 3
Totale 2.320
Nazione #
US - Stati Uniti d'America 905
SG - Singapore 387
CN - Cina 128
HK - Hong Kong 122
IE - Irlanda 105
IT - Italia 101
BR - Brasile 84
DE - Germania 66
VN - Vietnam 54
RU - Federazione Russa 53
FI - Finlandia 40
KR - Corea 40
GB - Regno Unito 22
IN - India 21
RO - Romania 20
FR - Francia 14
CA - Canada 13
SE - Svezia 10
AT - Austria 9
NL - Olanda 9
JP - Giappone 8
AR - Argentina 6
ES - Italia 6
IQ - Iraq 6
PL - Polonia 6
ZA - Sudafrica 5
BD - Bangladesh 4
ID - Indonesia 4
UA - Ucraina 4
UZ - Uzbekistan 4
BE - Belgio 3
CH - Svizzera 3
LT - Lituania 3
MD - Moldavia 3
NP - Nepal 3
SA - Arabia Saudita 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DK - Danimarca 2
IS - Islanda 2
KG - Kirghizistan 2
MA - Marocco 2
MX - Messico 2
PK - Pakistan 2
TR - Turchia 2
VE - Venezuela 2
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CM - Camerun 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
MY - Malesia 1
PA - Panama 1
PG - Papua Nuova Guinea 1
PY - Paraguay 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
ZM - Zambia 1
Totale 2.320
Città #
Singapore 271
Chandler 167
Hong Kong 121
Dublin 105
Ashburn 65
Boardman 59
Seoul 40
Santa Clara 39
Perugia 36
San Mateo 35
Munich 34
Los Angeles 31
Beijing 22
Helsinki 21
Timisoara 19
Lawrence 18
Medford 18
Princeton 18
Turku 17
Wilmington 17
Ho Chi Minh City 16
New York 16
Piscataway 16
Moscow 15
Altamura 14
Hanoi 14
São Paulo 14
Falls Church 13
Andover 12
Chennai 12
Des Moines 12
Brooklyn 10
Nuremberg 10
Redwood City 10
Dallas 8
Houston 8
Stockholm 8
Tokyo 8
London 7
Montreal 7
Rome 7
The Dalles 7
Boston 6
Poplar 6
West Jordan 6
Denver 5
Dong Ket 5
Fairfield 5
Hefei 5
Orem 5
Redmond 5
Atlanta 4
Chicago 4
Columbus 4
Milan 4
Saint Petersburg 4
Tashkent 4
Verona 4
Warsaw 4
Amsterdam 3
Belo Horizonte 3
Cosenza 3
Curitiba 3
Da Nang 3
El Paso 3
Frankfurt am Main 3
Johannesburg 3
Mumbai 3
Phoenix 3
Rio de Janeiro 3
San Paolo di Civitate 3
Vienna 3
Baghdad 2
Brixen 2
Brussels 2
Campinas 2
Carney 2
Casablanca 2
Chisinau 2
Dubai 2
Erbil 2
Falkenstein 2
Florence 2
Genoa 2
Grand Rapids 2
Guangzhou 2
Huzhou 2
Itabira 2
Lappeenranta 2
Manchester 2
Miami 2
Minneapolis 2
Ninh Bình 2
Ottawa 2
Pittsburgh 2
Porto Alegre 2
Raleigh 2
Reykjavik 2
Secaucus 2
Shanghai 2
Totale 1.572
Nome #
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 104
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 98
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 91
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 89
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 88
Levodopa-responsive breathing discomfort in Parkinson’s disease patients 87
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 82
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study 80
Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers 78
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 75
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease 75
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 73
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 71
Levodopa treatment in Parkinson's disease: earlier or later? 71
Drug-induced Creutzfeldt-Jakob disease-like syndrome: Early CSF analysis as useful tool for differential diagnosis 68
Molecular profiling in Parkinsonian syndromes: CSF biomarkers 67
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers. 64
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 63
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 62
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease 60
Blood biomarkers may distinguish among dementia disorders 59
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 59
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 56
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 53
Hyposmia correlates with axial signs and gait disorder in Parkinson's disease: an Italian Olfactory Identification Test study 53
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 52
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 50
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 50
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 50
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 47
Predictive value for cerebrospinal fluid Alzheimer's disease profile of different measures of verbal episodic memory in patients with MCI 45
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 43
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 43
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 42
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 41
Incidence and Risk Factors Epilepsy in Patients with Dementia: A Population-Based Study Using Regional Healthcare Databases in Umbria 34
Research advancement in fluid biomarkers for Parkinson's disease 30
Studying Alzheimer's disease through an integrative serum metabolomic and lipoproteomic approach 23
Totale 2.376
Categoria #
all - tutte 12.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.585


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 8 4 3 2 8 2 6
2021/2022134 0 23 0 0 5 8 4 34 10 11 20 19
2022/2023467 19 104 7 35 41 51 1 27 154 5 14 9
2023/2024253 16 25 8 4 4 2 42 6 46 12 45 43
2024/2025625 11 51 38 36 60 44 21 43 118 48 101 54
2025/2026785 98 104 60 191 212 120 0 0 0 0 0 0
Totale 2.376